Sarkis Jebejian is a partner in Cravath’s Corporate Department. His practice focuses primarily on mergers and acquisitions, both domestic and cross-border. Mr. Jebejian’s clients have included BAE Systems plc, PSEG, Genpact, Northrop Grumman, NextEra Energy, British American Tobacco plc and the independent directors of General Motors. Mr. Jebejian also provides governance and other general corporate advice to clients and their boards of directors, including with respect to compliance with the Dodd-Frank Act.
Most recently, Mr. Jebejian’s assignments include representing IBM in its acquisitions of Green Hat and Q1 Labs; Genpact in its acquisition of Headstrong; KKR Private Equity Investors in its combination transaction with KKR & Co. L.P. which achieved the public listing of KKR’s private equity business; WuXi Pharma in its proposed merger with Charles River Laboratories; the independent directors of General Motors in connection with the conversion of GMAC into a bank holding company and the related restructuring of GM’s investment in GMAC; the independent directors of Merrill Lynch in its acquisition by Bank of America; Grupo Modelo in connection with the hostile bid for Anheuser-Busch by InBev; the board of directors of National City Corp. in its acquisition by PNC Financial; United Airlines in connection with its consideration of various strategic transactions; BAE Systems in its acquisitions of Armor Holdings, United Defense Industries, MTC Technologies and numerous other matters; State Street Bank in its acquisition of Investors Financial Services; Steven Spielberg in connection with the formation of the new DreamWorks film studio in partnership with Reliance; Bacardi in its acquisition of Grey Goose Vodka; Kos Pharmaceuticals in its acquisition by Abbott Laboratories; the London Stock Exchange in connection with Nasdaq’s takeover bid; Florida Power & Light in its proposed merger with Constellation Energy, as well as other matters; GTECH in its acquisition by Lottomatica S.p.A.; British American Tobacco plc in the combination of its U.S. tobacco business with R.J. Reynolds; and the special committee of Kerzner International in its acquisition by management and a private equity consortium.
In 2012, Mr. Jebejian was chosen by corporate counsel as one of the BTI Client Service All-Stars for his exceptional commitment to understanding his clients’ legal and business objectives, recognizing client goals and providing innovative and effective solutions tailored specifically to the client’s desired outcome. Mr. Jebejian was named a “Star Partner” by The Lawyer in its Transatlantic Elite 2011 supplement for his work in the energy industry. In 2009 and 2010, he was recognized by The Legal 500 for his work in M&A: Mega-Deals. In 2008, Mr. Jebejian was named one of the top 500 leading lawyers in America by Lawdragon magazine. He is also a member of the Association of the Bar of the City of New York. In addition, Mr. Jebejian is one of the partners at Cravath who oversee the Firm’s pro bono projects involving the Montefiore Children’s Hospital and the Morgan Stanley Children’s Hospital of New York-Presbyterian through which free legal services are provided to patients and their families.
Mr. Jebejian was born in New York, New York. He received a B.A. from Columbia College in 1991 and a J.D. from Columbia University School of Law in 1994, where he was a Stone Scholar. Mr. Jebejian joined Cravath in 1994. From March 1996 through April 1998, he was based in Cravath’s Hong Kong office. He became a partner in 2002.
Mr. Jebejian may be reached by phone at 212-474-1188 or by email at sjebejian@cravath.com.